| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 13 | 2023 | 260 | 3.310 |
Why?
|
| Chronic Disease | 16 | 2021 | 983 | 3.200 |
Why?
|
| Child Health Services | 13 | 2021 | 51 | 3.140 |
Why?
|
| Radiography, Thoracic | 4 | 2025 | 333 | 1.670 |
Why?
|
| Health Services Needs and Demand | 8 | 2023 | 114 | 1.600 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2025 | 2777 | 1.540 |
Why?
|
| Home Care Services | 8 | 2022 | 77 | 1.510 |
Why?
|
| Child | 47 | 2024 | 7621 | 1.490 |
Why?
|
| Fee-for-Service Plans | 3 | 2024 | 31 | 1.430 |
Why?
|
| Insurance, Health | 5 | 2021 | 182 | 1.260 |
Why?
|
| Health Care Reform | 4 | 2018 | 86 | 1.260 |
Why?
|
| Lung Neoplasms | 8 | 2025 | 2384 | 1.130 |
Why?
|
| Caregivers | 7 | 2023 | 185 | 1.050 |
Why?
|
| Delivery of Health Care | 3 | 2024 | 468 | 1.050 |
Why?
|
| Scleroderma, Systemic | 8 | 2023 | 59 | 1.020 |
Why?
|
| Health Services Accessibility | 5 | 2021 | 491 | 0.990 |
Why?
|
| Hospitals, Pediatric | 10 | 2021 | 134 | 0.980 |
Why?
|
| Home Nursing | 2 | 2022 | 19 | 0.900 |
Why?
|
| Lung Diseases, Interstitial | 8 | 2023 | 292 | 0.870 |
Why?
|
| United States | 30 | 2023 | 7785 | 0.820 |
Why?
|
| Pediatrics | 4 | 2019 | 399 | 0.760 |
Why?
|
| Humans | 81 | 2025 | 95992 | 0.740 |
Why?
|
| Infant | 21 | 2023 | 3359 | 0.740 |
Why?
|
| Health Expenditures | 4 | 2021 | 101 | 0.730 |
Why?
|
| Child, Preschool | 22 | 2023 | 3969 | 0.710 |
Why?
|
| Primary Health Care | 4 | 2017 | 391 | 0.690 |
Why?
|
| Child Health | 2 | 2018 | 13 | 0.690 |
Why?
|
| Insurance | 1 | 2021 | 12 | 0.670 |
Why?
|
| Lung Diseases, Fungal | 1 | 2020 | 18 | 0.640 |
Why?
|
| Adolescent | 26 | 2022 | 9878 | 0.630 |
Why?
|
| Mucormycosis | 1 | 2020 | 17 | 0.630 |
Why?
|
| Health Equity | 1 | 2022 | 103 | 0.620 |
Why?
|
| Health Policy | 2 | 2019 | 208 | 0.600 |
Why?
|
| Health Services | 2 | 2016 | 58 | 0.600 |
Why?
|
| Telemedicine | 2 | 2022 | 229 | 0.600 |
Why?
|
| Rickets, Hypophosphatemic | 1 | 2019 | 1 | 0.590 |
Why?
|
| Infant Formula | 1 | 2019 | 18 | 0.580 |
Why?
|
| Carbohydrates | 1 | 2019 | 49 | 0.580 |
Why?
|
| Dietary Fats | 1 | 2019 | 137 | 0.550 |
Why?
|
| Phosphates | 1 | 2019 | 167 | 0.550 |
Why?
|
| Patient Rights | 1 | 2018 | 16 | 0.550 |
Why?
|
| Amino Acids | 1 | 2019 | 262 | 0.540 |
Why?
|
| Case Management | 1 | 2017 | 29 | 0.530 |
Why?
|
| Managed Care Programs | 1 | 2017 | 43 | 0.530 |
Why?
|
| Congresses as Topic | 1 | 2018 | 125 | 0.520 |
Why?
|
| Attitude of Health Personnel | 2 | 2013 | 683 | 0.510 |
Why?
|
| Lung | 6 | 2025 | 1380 | 0.510 |
Why?
|
| Patient Readmission | 7 | 2019 | 413 | 0.510 |
Why?
|
| Hospitalization | 7 | 2021 | 946 | 0.500 |
Why?
|
| Nursing Homes | 1 | 2017 | 113 | 0.490 |
Why?
|
| Health Status Indicators | 1 | 2016 | 104 | 0.480 |
Why?
|
| Residence Characteristics | 1 | 2017 | 213 | 0.470 |
Why?
|
| Retrospective Studies | 23 | 2023 | 10307 | 0.450 |
Why?
|
| Transition to Adult Care | 1 | 2015 | 23 | 0.430 |
Why?
|
| Cross-Sectional Studies | 10 | 2022 | 1880 | 0.420 |
Why?
|
| Infant, Newborn | 13 | 2021 | 2611 | 0.400 |
Why?
|
| Respiration, Artificial | 3 | 2020 | 425 | 0.370 |
Why?
|
| Male | 33 | 2021 | 45792 | 0.360 |
Why?
|
| Continuity of Patient Care | 3 | 2019 | 180 | 0.350 |
Why?
|
| Pneumococcal Infections | 2 | 2023 | 52 | 0.350 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 110 | 0.350 |
Why?
|
| Comprehensive Health Care | 1 | 2011 | 14 | 0.340 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2020 | 472 | 0.330 |
Why?
|
| Female | 33 | 2022 | 49980 | 0.330 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 229 | 0.330 |
Why?
|
| Emergency Service, Hospital | 4 | 2019 | 593 | 0.320 |
Why?
|
| Health Care Surveys | 6 | 2021 | 295 | 0.320 |
Why?
|
| Needs Assessment | 4 | 2018 | 171 | 0.310 |
Why?
|
| Forecasting | 2 | 2022 | 317 | 0.310 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 172 | 0.310 |
Why?
|
| Radiation Dosage | 3 | 2022 | 236 | 0.300 |
Why?
|
| Health Care Costs | 4 | 2021 | 255 | 0.300 |
Why?
|
| Neoplasm Staging | 2 | 2024 | 2042 | 0.290 |
Why?
|
| Patient Discharge | 5 | 2020 | 363 | 0.290 |
Why?
|
| Computed Tomography Angiography | 2 | 2021 | 166 | 0.290 |
Why?
|
| Radiologists | 2 | 2025 | 54 | 0.270 |
Why?
|
| Illinois | 3 | 2014 | 530 | 0.260 |
Why?
|
| Health Resources | 3 | 2019 | 82 | 0.250 |
Why?
|
| Subacute Care | 2 | 2017 | 19 | 0.250 |
Why?
|
| Physicians | 2 | 2021 | 707 | 0.230 |
Why?
|
| Australia | 3 | 2022 | 125 | 0.230 |
Why?
|
| Diagnosis, Differential | 4 | 2025 | 1618 | 0.230 |
Why?
|
| Fixation, Ocular | 1 | 2025 | 50 | 0.220 |
Why?
|
| Mediastinal Diseases | 1 | 2025 | 23 | 0.220 |
Why?
|
| Mediastinal Neoplasms | 1 | 2025 | 44 | 0.220 |
Why?
|
| Thoracic Neoplasms | 1 | 2025 | 66 | 0.220 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2025 | 105 | 0.210 |
Why?
|
| Streptococcus pneumoniae | 2 | 2023 | 56 | 0.200 |
Why?
|
| Pericardium | 1 | 2024 | 84 | 0.200 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2023 | 47 | 0.200 |
Why?
|
| Colorado | 1 | 2023 | 42 | 0.190 |
Why?
|
| Refugees | 1 | 2022 | 7 | 0.190 |
Why?
|
| Radiology | 1 | 2025 | 207 | 0.190 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 50 | 0.190 |
Why?
|
| Social Work | 1 | 2022 | 22 | 0.180 |
Why?
|
| Technology | 1 | 2022 | 35 | 0.180 |
Why?
|
| Vital Capacity | 2 | 2021 | 74 | 0.180 |
Why?
|
| Education, Medical, Continuing | 1 | 2023 | 112 | 0.180 |
Why?
|
| Consensus | 2 | 2021 | 372 | 0.180 |
Why?
|
| Insurance Coverage | 2 | 2021 | 144 | 0.180 |
Why?
|
| Cooperative Behavior | 1 | 2023 | 197 | 0.180 |
Why?
|
| Developed Countries | 1 | 2021 | 25 | 0.180 |
Why?
|
| Cohort Studies | 6 | 2021 | 3115 | 0.170 |
Why?
|
| Pleural Neoplasms | 1 | 2023 | 204 | 0.170 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 2860 | 0.170 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2021 | 61 | 0.170 |
Why?
|
| Multimorbidity | 1 | 2021 | 6 | 0.170 |
Why?
|
| Child, Hospitalized | 2 | 2019 | 41 | 0.170 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 492 | 0.160 |
Why?
|
| Health Services Research | 2 | 2011 | 148 | 0.160 |
Why?
|
| Length of Stay | 3 | 2019 | 835 | 0.160 |
Why?
|
| Cognition | 1 | 2025 | 635 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2019 | 2498 | 0.160 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2019 | 2 | 0.160 |
Why?
|
| Social Determinants of Health | 2 | 2018 | 111 | 0.160 |
Why?
|
| Respite Care | 1 | 2019 | 9 | 0.150 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2019 | 8 | 0.150 |
Why?
|
| Nursing, Private Duty | 1 | 2019 | 1 | 0.150 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 32 | 0.150 |
Why?
|
| Pandemics | 2 | 2024 | 880 | 0.150 |
Why?
|
| Young Adult | 6 | 2019 | 7034 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 129 | 0.150 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 147 | 0.150 |
Why?
|
| Multidetector Computed Tomography | 2 | 2024 | 61 | 0.150 |
Why?
|
| Workflow | 1 | 2019 | 80 | 0.150 |
Why?
|
| Telomere Shortening | 1 | 2019 | 25 | 0.150 |
Why?
|
| Sepsis | 1 | 2023 | 389 | 0.150 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 30 | 0.150 |
Why?
|
| Ataxia | 1 | 2019 | 47 | 0.140 |
Why?
|
| Adiponectin | 1 | 2018 | 21 | 0.140 |
Why?
|
| Drug Utilization | 1 | 2019 | 69 | 0.140 |
Why?
|
| Cross Infection | 1 | 2020 | 159 | 0.140 |
Why?
|
| Drug Costs | 1 | 2019 | 67 | 0.140 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2019 | 139 | 0.140 |
Why?
|
| Noninvasive Ventilation | 1 | 2019 | 42 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 3 | 2019 | 155 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2022 | 373 | 0.140 |
Why?
|
| Hospital Costs | 2 | 2016 | 117 | 0.140 |
Why?
|
| Telomere | 1 | 2019 | 121 | 0.140 |
Why?
|
| Critical Care | 1 | 2021 | 448 | 0.130 |
Why?
|
| Health Maintenance Organizations | 1 | 2017 | 20 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 151 | 0.130 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 3922 | 0.130 |
Why?
|
| Prevalence | 3 | 2017 | 1355 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2018 | 231 | 0.130 |
Why?
|
| Children's Health Insurance Program | 1 | 2016 | 2 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2021 | 442 | 0.120 |
Why?
|
| Contrast Media | 1 | 2021 | 1097 | 0.120 |
Why?
|
| Neuromuscular Diseases | 1 | 2016 | 29 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2017 | 108 | 0.120 |
Why?
|
| Respiratory Tract Diseases | 1 | 2016 | 47 | 0.120 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 401 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 117 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1741 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2019 | 205 | 0.120 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 26 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 296 | 0.120 |
Why?
|
| Catheter Ablation | 1 | 2019 | 365 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2013 | 858 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 790 | 0.120 |
Why?
|
| Esophagus | 1 | 2016 | 113 | 0.110 |
Why?
|
| Tonsillectomy | 1 | 2014 | 31 | 0.110 |
Why?
|
| Pregnancy | 1 | 2022 | 3239 | 0.110 |
Why?
|
| Cost Savings | 1 | 2014 | 71 | 0.110 |
Why?
|
| Adult | 8 | 2019 | 28636 | 0.110 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 66 | 0.100 |
Why?
|
| Emergencies | 1 | 2014 | 123 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 2042 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2014 | 218 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 3642 | 0.100 |
Why?
|
| Medicare | 2 | 2016 | 458 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 1144 | 0.090 |
Why?
|
| State Health Plans | 1 | 2011 | 13 | 0.090 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 467 | 0.080 |
Why?
|
| Child Welfare | 1 | 2011 | 44 | 0.080 |
Why?
|
| Community Health Services | 1 | 2011 | 81 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 484 | 0.080 |
Why?
|
| Algorithms | 2 | 2020 | 2018 | 0.080 |
Why?
|
| Competency-Based Education | 1 | 2010 | 38 | 0.080 |
Why?
|
| Family | 2 | 2022 | 331 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2011 | 323 | 0.080 |
Why?
|
| Risk Factors | 1 | 2020 | 5992 | 0.070 |
Why?
|
| Logistic Models | 1 | 2013 | 1273 | 0.070 |
Why?
|
| Dilatation | 2 | 2021 | 48 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 3155 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 640 | 0.070 |
Why?
|
| Hospitals | 1 | 2011 | 329 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2021 | 819 | 0.070 |
Why?
|
| Hospitalists | 1 | 2010 | 143 | 0.070 |
Why?
|
| Inpatients | 1 | 2011 | 348 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2885 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2019 | 9228 | 0.060 |
Why?
|
| Prognosis | 3 | 2019 | 3993 | 0.060 |
Why?
|
| Age Factors | 2 | 2021 | 1959 | 0.060 |
Why?
|
| Mediastinum | 1 | 2025 | 45 | 0.050 |
Why?
|
| Thorax | 1 | 2025 | 79 | 0.050 |
Why?
|
| Middle Aged | 6 | 2020 | 28299 | 0.050 |
Why?
|
| Pulmonologists | 1 | 2024 | 7 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2025 | 150 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1819 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 1018 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1176 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2025 | 207 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2023 | 33 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2014 | 2603 | 0.050 |
Why?
|
| Artifacts | 1 | 2025 | 254 | 0.050 |
Why?
|
| Educational Status | 1 | 2024 | 202 | 0.050 |
Why?
|
| Seasons | 1 | 2023 | 246 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 355 | 0.040 |
Why?
|
| Insurance Carriers | 1 | 2021 | 6 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 235 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2023 | 281 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2021 | 24 | 0.040 |
Why?
|
| Nurse Practitioners | 1 | 2021 | 34 | 0.040 |
Why?
|
| Pelvis | 1 | 2021 | 103 | 0.040 |
Why?
|
| Mental Health | 1 | 2022 | 202 | 0.040 |
Why?
|
| Income | 1 | 2021 | 90 | 0.040 |
Why?
|
| Abdomen | 1 | 2021 | 124 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 136 | 0.040 |
Why?
|
| Learning | 1 | 2024 | 305 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 81 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2020 | 46 | 0.040 |
Why?
|
| Serogroup | 1 | 2020 | 12 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2024 | 476 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 25 | 0.040 |
Why?
|
| Skin | 1 | 2023 | 604 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 50 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 153 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 84 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2019 | 21 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 348 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 37 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2019 | 17 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 220 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 7 | 0.040 |
Why?
|
| Incidence | 1 | 2023 | 1723 | 0.040 |
Why?
|
| United Kingdom | 1 | 2019 | 192 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 311 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 94 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2019 | 376 | 0.030 |
Why?
|
| Patient Admission | 1 | 2018 | 122 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1017 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 277 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 666 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2019 | 465 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 43 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 2575 | 0.030 |
Why?
|
| Internet | 1 | 2018 | 340 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 56 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 308 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 740 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1130 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2018 | 403 | 0.030 |
Why?
|
| Poverty | 1 | 2017 | 196 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 600 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 4690 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 444 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 848 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1962 | 0.030 |
Why?
|
| Radiation Protection | 1 | 2013 | 28 | 0.020 |
Why?
|
| Radiometry | 1 | 2013 | 61 | 0.020 |
Why?
|
| Registries | 1 | 2018 | 998 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2013 | 32 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1931 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 438 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 1014 | 0.020 |
Why?
|
| Medical Laboratory Science | 1 | 2011 | 7 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2011 | 161 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 68 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1978 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2013 | 490 | 0.020 |
Why?
|
| Social Support | 1 | 2011 | 239 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 20927 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 594 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 5593 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7224 | 0.020 |
Why?
|
| Curriculum | 1 | 2010 | 616 | 0.010 |
Why?
|